These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20051663)

  • 21. Depressive symptoms and white matter changes in patients with dementia.
    Lind K; Jonsson M; Karlsson I; Sjögren M; Wallin A; Edman A
    Int J Geriatr Psychiatry; 2006 Feb; 21(2):119-25. PubMed ID: 16416468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virchow-Robin space dilatation may predict resistance to antidepressant monotherapy in elderly patients with depression.
    Patankar TF; Baldwin R; Mitra D; Jeffries S; Sutcliffe C; Burns A; Jackson A
    J Affect Disord; 2007 Jan; 97(1-3):265-70. PubMed ID: 16919335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant efficacy and cognitive effects of repetitive transcranial magnetic stimulation in vascular depression: an open trial.
    Fabre I; Galinowski A; Oppenheim C; Gallarda T; Meder JF; De Montigny C; Olié JP; Poirier MF
    Int J Geriatr Psychiatry; 2004 Sep; 19(9):833-42. PubMed ID: 15352140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mood and neuropsychological changes in women with midlife depression treated with escitalopram.
    Wroolie TE; Williams KE; Keller J; Zappert LN; Shelton SD; Kenna HA; Reynolds MF; Rasgon NL
    J Clin Psychopharmacol; 2006 Aug; 26(4):361-6. PubMed ID: 16855452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Placebo response and antidepressant response.
    Alexopoulos GS; Kanellopoulos D; Murphy C; Gunning-Dixon F; Katz R; Heo M
    Am J Geriatr Psychiatry; 2007 Feb; 15(2):149-58. PubMed ID: 17272735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attention and executive functions in remitted major depression patients.
    Paelecke-Habermann Y; Pohl J; Leplow B
    J Affect Disord; 2005 Dec; 89(1-3):125-35. PubMed ID: 16324752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment.
    Zobel AW; Schulze-Rauschenbach S; von Widdern OC; Metten M; Freymann N; Grasmäder K; Pfeiffer U; Schnell S; Wagner M; Maier W
    J Psychiatr Res; 2004; 38(4):377-83. PubMed ID: 15203289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progression of cerebral white matter lesions is not associated with development of depressive symptoms in elderly subjects at risk of cardiovascular disease: The PROSPER Study.
    Versluis CE; van der Mast RC; van Buchem MA; Bollen EL; Blauw GJ; Eekhof JA; van der Wee NJ; de Craen AJ;
    Int J Geriatr Psychiatry; 2006 Apr; 21(4):375-81. PubMed ID: 16534770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An open-label study of escitalopram (Lexapro) for the treatment of 'Depression of Alzheimer's disease' (dAD).
    Rao V; Spiro JR; Rosenberg PB; Lee HB; Rosenblatt A; Lyketsos CG
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):273-4. PubMed ID: 16477587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of depression--newer pharmacotherapies.
    Mulrow CD; Williams JW; Trivedi M; Chiquette E; Aguilar C; Cornell JE; Badgett R; Noël PH; Lawrence V; Lee S; Luther M; Ramirez G; Richardson WS; Stamm K
    Psychopharmacol Bull; 1998; 34(4):409-795. PubMed ID: 10513454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders: a longitudinal analysis.
    Goldberg JF; Harrow M
    J Affect Disord; 2005 Dec; 89(1-3):79-89. PubMed ID: 16249035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frontal lobe atrophy is associated with small vessel disease in ischemic stroke patients.
    Chen Y; Chen X; Xiao W; Mok VC; Wong KS; Tang WK
    Clin Neurol Neurosurg; 2009 Dec; 111(10):852-7. PubMed ID: 19744770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL.
    Viswanathan A; Gschwendtner A; Guichard JP; Buffon F; Cumurciuc R; O'Sullivan M; Holtmannspötter M; Pachai C; Bousser MG; Dichgans M; Chabriat H
    Neurology; 2007 Jul; 69(2):172-9. PubMed ID: 17620550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of an acute antidepressant response to fluoxetine and sertraline.
    Flament MF; Lane RM; Zhu R; Ying Z
    Int Clin Psychopharmacol; 1999 Sep; 14(5):259-75. PubMed ID: 10529069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
    Honig A; Kuyper AM; Schene AH; van Melle JP; de Jonge P; Tulner DM; Schins A; Crijns HJ; Kuijpers PM; Vossen H; Lousberg R; Ormel J;
    Psychosom Med; 2007; 69(7):606-13. PubMed ID: 17846258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Executive dysfunction in medicated, remitted state of major depression.
    Nakano Y; Baba H; Maeshima H; Kitajima A; Sakai Y; Baba K; Suzuki T; Mimura M; Arai H
    J Affect Disord; 2008 Nov; 111(1):46-51. PubMed ID: 18304646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of white matter lesions and lacunar infarcts with executive functioning: the SMART-MR study.
    Geerlings MI; Appelman AP; Vincken KL; Mali WP; van der Graaf Y;
    Am J Epidemiol; 2009 Nov; 170(9):1147-55. PubMed ID: 19783584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Location and progression of cerebral small-vessel disease and atrophy, and depressive symptom profiles: the Second Manifestations of ARTerial disease (SMART)-Medea study.
    Grool AM; van der Graaf Y; Mali WP; Witkamp TD; Vincken KL; Geerlings MI;
    Psychol Med; 2012 Feb; 42(2):359-70. PubMed ID: 21835088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.